← FDA Drug Approvals (Drugs@FDA)

CLONAZEPAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2026-05-21

Drug application

FDA Application #

ANDA216988

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLONAZEPAM

Generic name

CLONAZEPAM

Active ingredients

CLONAZEPAM

Dosage form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Marketing status

Prescription

Sponsor

RUBICON RESEARCH

Manufacturer

Advagen Pharma Ltd

First approval

2026-05-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown